Background Onchocerciasis transmission across international borders is not uncommon, yet a coordinated cross border stops mass drug administration (MDA) decision has not been documented. Methods/Principle findings The Galabat-Metema focus involves neighboring districts on the border between Sudan and Ethiopia. Mass drug administration (MDA) was provided once and subsequently twice per year in this focus, with twice-per-year beginning in Ethiopia's Metema subfocus in 2016 and in the Sudan's Galabat subfocus in 2008. Ov16 ELISA-based serosurveys were conducted in 6072 children under 10 years of age in the Metema subfocus in 2014, and 3931 in the Galabat in 2015. Between 2014 and 2016, a total of 27,583 vector Simulium damnosum flies from Metema and 9,148 flies from Galabat were tested by pool screen PCR for Onchocerca volvulus O-150 DNA. Only 8 children were Ov16 seropositive (all in the Metema subfocus); all were negative by skin snip PCR. The upper limit of the 95% confidence interval (UCL) for Ov16 seropositive was <0.1% for the overall focus and 0.14 positive fly heads per 2000 (UCL = 0.39/2000). However, an entomological 'hotspot' was detected on the Wudi Gemzu river in Metema district. The hotspot was confirmed when 4 more positive fly pools
Background: The prevalence of opportunistic intestinal parasites is expected to be high among Human Immune Deficiency Virus infected populations in developing countries. For many years, intestinal infections caused by opportunistic organisms have been represented as a major problem in immune compromised patients with Acquired Immune Deficiency Syndromes.Methods: Institution based comparative cross sectional study design was conducted in Gendewoyn health center, Goncha Siso Enesie woreda from March to June 2014. A structured questionnaire was administered to all participants to obtain information on socio demographic characteristics and their source of drinking water. For the laboratory test using a direct saline, Dobell's iodine separate wet mount, formal ether concentration and modified Ziehl-Neelsen (Zn) method was applied. The minimum sample size for this quantitative study was 312. Binary and multiple logistic regressions were used to identify factors of intestinal parasite infection and odds ratios, 95% CI and p-value were computed to measure the presence and strength of associations. Results:The overall prevalence of intestinal parasite infections in pre-ART and on-ART was 53.7% and 36.5%, respectively with significant decrease of intestinal parasite in the ART era (p<0.006). Majority of Cryptosporidium species infections were found in the pre-ART patients and significantly associated for lower CD4<500 cells/mm 3 . Absence of toilet (AOR=1.80; 95% CI=1.090-2.975), source of water (AOR=8.260; 95% CI=4.659-14.642), rural residence (AOR=2.292, 95% CI=1.386-3.788); CD4 counts (AOR=1.559; 95% CI=1.093-2.722) HAART status: pre ART patients (AOR=2.13, CI, 1.167-3.905) have significant association with prevalence of intestinal parasite infections. Conclusion and recommendations:The most prevalent parasite in the pre-ART subjects were ova of Ascaris lumbricoides (15.7%) followed by Enteamoeba histolytica (14.8%) while on ART patients the most prevalent parasites were ova of Ascaris lumbricoides (8.8%) and cyst of Enteamoeba histolytica (7.4%). The present study revealed the importance of examining pre-ART and on ART patients for intestinal parasite infections. This study reminded health professionals regarding the occurrence of these parasites in this population. Routine examination of stool samples for parasitic infections could significantly benefit pre-ART and on ART patients for early treatment.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.